logo
Plus   Neg
Share
Email

Salzgitter Suspends Dividend

Salzgitter (SZGPF.PK,SZGPY.PK) has suspended dividend for the financial year 2019, citing the uncertainties caused by the impact of COVID-19.

The company noted that the global constraints on economic activities resulting from the Corona pandemic have had considerable impact on the company's course of business. Consequently, the original proposal for the distribution of profit no longer seems appropriate.

Therefore, the Executive Board and Supervisory Board will submit a proposal to the Annual General Meeting of Shareholders to carry forward the unappropriated retained earnings for the financial year 2019 to new account and, for the first time since the the company's listing in 1998, not to pay dividend, Salzgitter said in a statement.

The company also decided to postpone the Annual General Meeting of Shareholders planned for May 28, 2020 to July 8, 2020, and to hold the meeting as a virtual event.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Chico's FAS Inc. (CHS) Tuesday reported a wider year-over-year net loss for the fourth quarter. Meanwhile, Kohl's Corp.'s (KSS) fourth-quarter net income grew 29 percent from the previous year. But Abercrombie & Fitch Co.'s (ANF) fourth-quarter net income decreased 1 percent from the prior year. The U.S. Food and Drug Administration has approved the marketing of a new robotically-assisted surgical device (RASD) that can facilitate transvaginal hysterectomy in certain patients using minimally-invasive surgical instruments. The Hominis Surgical System of Memic Innovative Surgery Ltd., the U.S. subsidiary of Israeli biotechnology company memic Ltd., has been granted marketing authorization. Canadian cannabis company Canopy Growth Corp. (CGC, WEED.TO) announced Tuesday the launch of its Cannabidiol (CBD) beverage brand Quatreau in the high-potential U.S. market. Quatreau will be sold on Canopy's one-stop U.S. e-commerce destination, www.shopcanopy.com. Quatreau is a premium ready-to-drink...
Follow RTT